Study of Ayurvedic decoction (Madanphaladi kwath) in participants of Obesity (Sthaulya) associated with raised serum cholesterol levels.

Study of Apatarpan Chikitsa Siddhanta with special reference to efficacy of Madanphaladi kwath in Sthaulya associated with Hypercholesterolemia. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059645

Enrollment

100

Registered

2023-11-08

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E780- Pure hypercholesterolemia Health Condition 2: E660- Obesity due to excess calories

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects between age group 20-30 years irrespective of gender, religion, socioeconomic strata will be selected. 2. Subjects having signs and symptoms of Sthaulya (Medorog) that is Atikshudha, Atipipasa, Swedadhikya, Nidradhikya, Daurbalya, Sweda durgandhya etc. [13] 3. Subjects having BMI between 25-34.9 with raised serum cholesterol range between 200- 239 mg/dl on laboratory investigations.

Exclusion criteria

Exclusion criteria: 1. Subjects having severe hypertension, endocrine disorders, Cushingâ??s Syndrome, any major disease or other associated complications. 2. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
TO STUDY OF APATARPAN CHIKITSA SIDDHANTA WITH SPECIAL REFERENCE TO EFFICACY OF MADANPHALADI KWATH IN STHAULYA ASSOCIATED WITH HYPERCHOLESTEROLEMIATimepoint: 12 weeks	—

Secondary

Measure	Time frame
1. The effect of drug will be assessed on the basis of the subjective as well as objective parameters. 2. The Subjective parameters will be based on signs and symptoms of Sthaulya compiled from classical references and difference will be assessed by the Gradation method. Percentage of relief in Symptoms will be calculated according to the difference between pre-treatment total symptoms score and post treatment total symptoms score. 3.Serum Cholesterol, Serum HDL, Serum LDL, Serum Triglyceride and BMI will be carried out before and after study (on Day 0 and Day 90).Timepoint: 6-7 Months.	—

Measure

Time frame

1. The effect of drug will be assessed on the basis of the subjective as well as objective parameters. 2. The Subjective parameters will be based on signs and symptoms of Sthaulya compiled from classical references and difference will be assessed by the Gradation method. Percentage of relief in Symptoms will be calculated according to the difference between pre-treatment total symptoms score and post treatment total symptoms score. 3.Serum Cholesterol, Serum HDL, Serum LDL, Serum Triglyceride and BMI will be carried out before and after study (on Day 0 and Day 90).Timepoint: 6-7 Months.

—

Countries

India

Contacts

Public ContactDr Prajakta Subhash Bodkhe

MAMs Sumatibhai shah ayurved college, Hadapsar, Pune

drgssawant@gmail.com8275563531

Outcome results